Abstract
Obesity and its associated metabolic syndromes such as type 2 diabetes represent a global epidemic health problem. Metabolic inflammation, lipid accumulation and insulin resistance contribute to the progression of these diseases, thus becoming targets for drug development. Epidemiological data have shown that the rate of helminth infection correlates negatively with the incidence of obesi…